Jui
Jui Chang, Hsin-Chu TW
Patent application number | Description | Published |
---|---|---|
20160054646 | PROJECTOR - A projector includes a light source module, an optical engine, a light valve and a projecting lens. The light source module includes light sources, optical fibers and a light integration rod. Each of the light sources provides an illumination sub-beam. Each of the illumination sub-beams transmits to the light integration rod through the corresponding optical fiber, and passes through the light integration rod and emits out to form a first illumination beam. The optical engine includes a phosphor wheel located at a transmission path of the first illumination beam and converting the first illumination beam into a second illumination beam. The light valve is located at a transmission path of the second illumination beam and converts the second illumination beam into an image beam. The projecting lens is located at a transmission path of the image beam and projects the image beam out of the projector. | 02-25-2016 |
Jui Lim, Singapore SG
Patent application number | Description | Published |
---|---|---|
20130023769 | Tissue Penetration Device Coupled with Ultrasound Scanner - Embodiments provide a device for penetrating a tissue of a subject. The device comprises a tissue penetrating portion having a tissue penetrating end. The device further comprises an ultrasonic scanner coupled to the tissue penetrating portion. The ultrasonic scanner comprises an ultrasound transduction circuit being configured to generate and transmit ultrasound waves to the subject and to receive returned sound waves echoed from the subject. The ultrasonic scanner further comprises a pulse generating circuit being configured to generate an electrical pulse so that the ultrasound transduction circuit is triggered to generate and transmit ultrasound waves. | 01-24-2013 |
Jui Liu, Emeryville, CA US
Patent application number | Description | Published |
---|---|---|
20100075965 | PI3 KINASE INHIBITORS AND METHODS OF THEIR USE - Phosphatidylinositol (PI) 3 kinase inhibitor compounds, their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, phospholipid kinases, G-protein coupled receptors, and phosphatases. | 03-25-2010 |